QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Biomerica, Inc. (NASDAQ:BMRA), a global biomedical company, announced today a marketing services arrangement with Henry Schein,...

Core News & Articles

- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributo...

 biomerica-q1-sales-1380m-down-from-1807m-yoy

Biomerica (NASDAQ:BMRA) reported $1.380 million in sales this quarter. This is a 23.63 percent decrease over sales of $1.807 mi...

 biomerica-launches-ai-powered-tool-to-help-ibs-patients-manage-symptoms-and-avoid-trigger-foods-identified-by-infoods-testing

New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFo...

 reported-earlier-biomericas-10-minute-h-pylori-home-test-approved-in-uae

10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH....

 reported-earlier-biomerica-has-been-granted-canadian-patent-number-3145879-titled-compositions-devices-and-methods-of-ibs-sensitivity-testing

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3145879/summary.html

 biomericas-infoods-ibs-test-receives-ama-pla-code-advancing-path-to-insurance-reimbursement-and-wider-patient-access

PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insur...

 biomericas-infoods-ibs-test-featured-in-prestigious-journal-gastroenterology-as-landmark-peer-reviewed-study-demonstrates-symptom-improvement-in-ibs-patients-through-personalized-non-drug-dietary-therapy

Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Tes...

 biomerica-announces-real-world-results-showing-effectiveness-of-infoods-ibs-product-along-with-launch-of-proprietary-real-time-patient-feedback-system-to-enhance-symptom-tracking-and-improve-patient-outcomes

Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointesti...

 announces-the-co-and-its-clia-laboratory-partner-have-submitted-an-application-to-the-american-medical-association-cpt-editorial-panel-requesting-the-assignment-of-a-proprietary-laboratory-analysis-code-for-the-infoods-ibs-diagnostic-test

- Application represents milestone toward broadening patient access to inFoods IBS- inFoods® IBS pinpoints patient-specific foo...

 biomericas-fortel-ulcer-test-approved-for-sale-in-uae-enabling-rapid-10-minute-detection-of-helicobacter-pylori-a-class-1-carcinogen-linked-to-80-of-gastric-cancer-casesoffering-fast-accessible-diagnostic-tool-amid-growing-regional-gi-health-concerns

10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproxi...

 uae-ministry-of-health-and-prevention-approves-biomericas-fortel-kidney-disease-test-for-sale

Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidn...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION